Joseph Romanelli - Dec 2, 2022 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role: President, Human Health Int?l
Signature: /s/ Jon Filderman, attorney-in-fact for Joseph Romanelli
Stock symbol: MRK
Transactions as of: Dec 2, 2022
Transactions value $: $40,673
Form type: 4
Date filed: 6/30/2023, 04:04 PM
Previous filing: Jul 26, 2022
Next filing: Feb 16, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MRK	Common Stock	Purchase	$6.47K	+59		$109.67	59	Dec 2, 2022	By Spouse	F1
transaction	MRK	Common Stock	Purchase	$11.7K	+107	+0.53%	$109.54	20.4K	Dec 5, 2022	Direct	F1
transaction	MRK	Common Stock	Purchase	$3.28K	+30	+0.15%	$109.39	20.4K	Dec 6, 2022	Direct	F1
transaction	MRK	Common Stock	Purchase	$6.21K	+56	+0.27%	$110.96	20.5K	Dec 13, 2022	Direct	F1
transaction	MRK	Common Stock	Purchase	$763	+7	+0.03%	$109.04	20.5K	Dec 19, 2022	Direct	F1
transaction	MRK	Common Stock	Purchase	$1.2K	+11	+0.05%	$109.20	20.5K	Feb 21, 2023	Direct	F1
transaction	MRK	Common Stock	Purchase	$14.3K	+136	+0.66%	$105.47	20.6K	Mar 20, 2023	Direct	F1
transaction	MRK	Common Stock	Sale	-$3.66K	-35	-0.17%	$104.65	20.6K	Mar 24, 2023	Direct	F1
transaction	MRK	Common Stock	Purchase	$341	+3	+0.01%	$113.68	20.6K	Apr 26, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	None of the purchases or sales reported herein were directed by the reporting person, but were executed by a brokerage firm for the benefit of the reporting person's managed account, without the reporting person's knowledge. One of the reported transactions resulted in a short swing profit under Section 16(b) of the Securities Exchange Act of 1934, as amended ("Section 16(b)"), and the reporting person has disgorged $374.01 to the Issuer, which amount represents all profits related to these transactions in accordance with Section 16(b).

Content

None of the purchases or sales reported herein were directed by the reporting person, but were executed by a brokerage firm for the benefit of the reporting person's managed account, without the reporting person's knowledge. One of the reported transactions resulted in a short swing profit under Section 16(b) of the Securities Exchange Act of 1934, as amended ("Section 16(b)"), and the reporting person has disgorged $374.01 to the Issuer, which amount represents all profits related to these transactions in accordance with Section 16(b).